ADP
58
-4
BEN
52
10
LMT
55
-5
TDC
67
2
CL
64
3
UAL
66
8
MMC
48
-3
GOOG
97
14
HES
79
2
CRM
49
5
HON
53
-4
MAC
71
4
DO
58
6
LOW
55
6
NEE
54
-3
THC
70
-2
WHR
36
-10
BIIB
45
3
MET
45
5
L
50
-5
ADP
58
-4
BEN
52
10
LMT
55
-5
TDC
67
2
CL
64
3
UAL
66
8
MMC
48
-3
GOOG
97
14
HES
79
2
CRM
49
5
HON
53
-4
MAC
71
4
DO
58
6
LOW
55
6
NEE
54
-3
THC
70
-2
WHR
36
-10
BIIB
45
3
MET
45
5
L
50
-5
Financhill
Back

WAVE Life Sciences 10K Form

Sell
25

WVE
WAVE Life Sciences

Last Price:
4.84
Seasonality Move:
14.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q WVE/WAVE Life Sciences Quarterly
2023-08-03 10Q WVE/WAVE Life Sciences Quarterly
2023-05-03 10Q WVE/WAVE Life Sciences Quarterly
2022-11-10 10Q WVE/WAVE Life Sciences Quarterly
2022-08-11 10Q WVE/WAVE Life Sciences Quarterly
2022-05-12 10Q WVE/WAVE Life Sciences Quarterly

Receive WVE News And Ratings

See the #1 stock for the next 7 days that we like better than WVE

WVE Financial Statistics

Sales & Book Value

Annual Sales: $113.31M
Cash Flow: $-33.6M
Price / Cash Flow: 0
Annual Sales: $0.33
Price / Book: 14.97

Profitability

EPS (TTM): -0.55000
Net Income (TTM): $-57.51M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: -25.71%

WAVE Life Sciences Earnings Forecast

Key WAVE Life Sciences Financial Ratios

  • The Selling, General & Administrative Expenses for WVE have been equal to 45.27% of Gross Profit Margin.
  • The Research & Development expenses have been 114.74% of Revenue.
  • The Net Earning history of WVE is -50.76% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

WAVE Life Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: WVE
CUSIP: Y95308
Website: wavelifesciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.26
Quick Ratio: 1.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

WVE Technical Analysis vs Fundamental Analysis

Sell
25
WAVE Life Sciences (WVE) is a Sell

Is WAVE Life Sciences a Buy or a Sell?

  • WAVE Life Sciences stock is rated a Sell
    The current WAVE Life Sciences [WVE] share price is $4.85. The Score for WVE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.